Compare PEPG & OEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PEPG | OEC |
|---|---|---|
| Founded | 2018 | 1862 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.6M | 295.3M |
| IPO Year | 2022 | 2014 |
| Metric | PEPG | OEC |
|---|---|---|
| Price | $5.47 | $6.42 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 5 | 3 |
| Target Price | ★ $10.80 | $6.67 |
| AVG Volume (30 Days) | ★ 684.0K | 578.3K |
| Earning Date | 02-23-2026 | 02-17-2026 |
| Dividend Yield | N/A | ★ 1.29% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,829,200,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.88 | $4.35 |
| 52 Week High | $7.80 | $16.63 |
| Indicator | PEPG | OEC |
|---|---|---|
| Relative Strength Index (RSI) | 46.18 | 64.89 |
| Support Level | $5.31 | $5.76 |
| Resistance Level | $6.20 | $6.58 |
| Average True Range (ATR) | 0.57 | 0.33 |
| MACD | -0.11 | 0.04 |
| Stochastic Oscillator | 23.03 | 87.88 |
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
Orion SA is a manufacturer of carbon black products. Carbon black is a powdered form of carbon used to create the desired physical, electrical and optical qualities of various materials. The company's operating segments are Specialty Carbon Black and Rubber Carbon Black. It generates maximum revenue from the Rubber Carbon Black segment. Rubber Carbon Black segment is used in the reinforcement of rubber in tires and mechanical rubber goods. The Specialty Carbon Black segment is used as pigments and performance additives in coatings, polymers, printing and special applications. Geographically, it derives a majority of its revenue from Germany.